Tevogen Inc.
TVGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001860871
No open-market purchases or sales by Tevogen Inc. insiders were filed in the last 90 days; 30 institutions reported holding it in 13F filings for Q2 2026, worth $607.7K in total; no superinvestor holds it.
Other share classesTVGNW
13F holders, Q1 2024
Institutional positions in Tevogen Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 5
- +5 vs. Q4 2023
- Shares held
- 6.78M
- +6.78M vs. Q4 2023
- Total value
- $30.7M
- +$30.7M vs. Q4 2023
- New holders
- 5
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TVGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $607.7K |
| Q1 2026 | 30 | $614.1K |
| Q4 2025 | 51 | $1.68M |
| Q3 2025 | 52 | $3.78M |
| Q2 2025 | 55 | $6.04M |
| Q1 2025 | 51 | $4.16M |
| Q4 2024 | 44 | $2.49M |
| Q3 2024 | 35 | $2.08M |
| Q2 2024 | 27 | $2.89M |
| Q1 2024 | 5 | $30.7M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Tevogen Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Portland Global Advisors LLC | 5,782,209 | $21.7M | 2.96% | +5,782,209 | New |
| Polar Asset Management Partners Inc. | 334,615 | $6.19M | 0.17% | +334,615 | New |
| Cantor Fitzgerald, L. P. | 650,000 | $2.77M | 0.66% | +650,000 | New |
| HRT Financial LP | 12,278 | $45.0K | 0.00% | +12,278 | New |
| JPMorgan Chase & Co | 30 | $112 | 0.00% | +30 | New |